Requires Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating.

This bill mandates Medicaid coverage for FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating behaviors. The Department of Health must develop rules and clinical criteria for coverage, streamline prior authorization forms, evaluate health outcomes, and report annually on utilization and costs. The bill also authorizes the Department of Health to implement step therapy protocols, prior authorization, income-based eligibility prioritization, and documentation requirements for autism-related needs.

Requires Medicaid coverage of FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating.

This bill mandates Medicaid coverage for FDA-approved GLP-1 receptor agonist medications for obesity, metabolic disorders, and autism-related compulsive eating behaviors. The Department of Health must develop rules and clinical criteria for coverage, streamline prior authorization forms, evaluate health outcomes, and report annually on utilization and costs. The bill also authorizes the Department of Health to implement step therapy protocols, prior authorization, income-based eligibility prioritization, and documentation requirements for autism-related needs.